Temporal evolution of myocardial hemorrhage and edema in patients after acute st-segment elevation myocardial infarction:Pathophysiological insights and clinical implications by Carrick, David et al.
                                                                    
University of Dundee
Temporal evolution of myocardial hemorrhage and edema in patients after acute st-
segment elevation myocardial infarction
Carrick, David; Haig, Caroline; Ahmed, Nadeem; Rauhalammi, Samuli; Clerfond, Guillaume;
Carberry, Jaclyn
Published in:
Journal of the American Heart Association
DOI:
10.1161/JAHA.115.002834
Publication date:
2016
Link to publication in Discovery Research Portal
Citation for published version (APA):
Carrick, D., Haig, C., Ahmed, N., Rauhalammi, S., Clerfond, G., Carberry, J., ... Berry, C. (2016). Temporal
evolution of myocardial hemorrhage and edema in patients after acute st-segment elevation myocardial
infarction: Pathophysiological insights and clinical implications. Journal of the American Heart Association, 5(2),
[e002834]. https://doi.org/10.1161/JAHA.115.002834
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 24. Nov. 2019
Temporal Evolution of Myocardial Hemorrhage and Edema in Patients
After Acute ST-Segment Elevation Myocardial Infarction:
Pathophysiological Insights and Clinical Implications
David Carrick, MRCP; Caroline Haig, PhD; Nadeem Ahmed, MBChB; Samuli Rauhalammi, MSc; Guillaume Clerfond, MD; Jaclyn Carberry,
BMedSci; Ify Mordi, MRCP; Margaret McEntegart, MRCP; Mark C. Petrie, MRCP; Hany Eteiba, FRCP; Stuart Hood, FRCP; Stuart Watkins,
FRCP; M. Mitchell Lindsay, FRCP; Ahmed Mahrous, PhD; Paul Welsh, PhD; Naveed Sattar, PhD; Ian Ford, PhD; Keith G. Oldroyd, FRCP;
Aleksandra Radjenovic, PhD; Colin Berry, FRCP
Background-—The time course and relationships of myocardial hemorrhage and edema in patients after acute ST-segment
elevation myocardial infarction (STEMI) are uncertain.
Methods and Results-—Patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary
intervention underwent cardiac magnetic resonance imaging on 4 occasions: at 4 to 12 hours, 3 days, 10 days, and 7 months after
reperfusion. Myocardial edema (native T2) and hemorrhage (T2*) were measured in regions of interest in remote and injured
myocardium. Myocardial hemorrhage was taken to represent a hypointense infarct core with a T2* value <20 ms. Thirty patients with
ST-segment elevation myocardial infarction (mean age 54 years; 25 [83%] male) gave informed consent. Myocardial hemorrhage
occurred in 7 (23%), 13 (43%), 11 (33%), and 4 (13%) patients at 4 to 12 hours, 3 days, 10 days, and 7 months, respectively,
consistent with a unimodal pattern. The corresponding median amounts of myocardial hemorrhage (percentage of left ventricular
mass) during the ﬁrst 10 days after myocardial infarction were 2.7% (interquartile range [IQR] 0.0–5.6%), 7.0% (IQR 4.9–7.5%), and
4.1% (IQR 2.6–5.5%; P<0.001). Similar unimodal temporal patterns were observed for myocardial edema (percentage of left
ventricular mass) in all patients (P=0.001) and for infarct zone edema (T2, in ms: 62.1 [SD 2.9], 64.4 [SD 4.9], 65.9 [SD 5.3]; P<0.001)
in patients without myocardial hemorrhage. Alternatively, in patients with myocardial hemorrhage, infarct zone edemawas reduced at
day 3 (T2, in ms: 51.8 [SD 4.6]; P<0.001), depicting a bimodal pattern. Left ventricular end-diastolic volume increased from baseline to
7 months in patients with myocardial hemorrhage (P=0.001) but not in patients without hemorrhage (P=0.377).
Conclusions-—The temporal evolutions of myocardial hemorrhage and edema are unimodal, whereas infarct zone edema (T2 value)
has a bimodal pattern. Myocardial hemorrhage is prognostically important and represents a target for therapeutic interventions
that are designed to preserve vascular integrity following coronary reperfusion.
Clinical Trial Registration-—URL: https://clinicaltrials.gov/. Unique identiﬁer: NCT02072850. ( J Am Heart Assoc. 2016;5:
e002834 doi: 10.1161/JAHA.115.002834)
Key Words: magnetic resonance imaging • myocardial edema • myocardial hemorrhage • myocardial infarction •
pathophysiology • reperfusion injury
I n acute ST-segment elevationmyocardial infarction (STEMI),myocardial hemorrhage is a complication that is associated
with the duration of ischemia and reperfusion1–4 and that is an
adverse prognostic factor in the longer term.5–8 Myocardial
hemorrhage is potentially a therapeutic target for novel
interventions; however, the temporal evolution of myocardial
hemorrhage and its associationwith othermyocardial infarction
(MI) pathologies early after MI are incompletely understood.
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Myocardial edema is a consequence of ischemia and
infarction and has functional importancebecause edema impairs
myocyte contractility.9 The extent ofmyocardial edema revealed
by T2-weighted cardiac magnetic resonance (CMR) imaging
correlates with the transmural extent of infarction.10,11 For
myocardial edema to be taken as a retrospective marker of the
area at risk,12,13 its initial size should be stable. Dall’Armelina
et al14 reported that the extent of edemawasmaximal within the
ﬁrst 5 to 7 days after MI but then decreased in size subse-
quently. Recently, Fernandez-Jimenez et al15,16 assessed
myocardial edema in a swine model of MI (with or without
reperfusion) at 2 hours, 24 hours, 4 days, or 7 days (n=5 per
group) usingCMRandquantiﬁcationofmyocardialwater content
by postmortem tissue desiccation. They observed bimodal peaks
in transverse relaxation times (T2, in ms) reﬂecting myocardial
water content at 2 hours and 7 days after reperfusion and an
intervening decrease in myocardial water content at 24 hours.
They concluded that myocardial edema was not stable and that
the bimodal accumulation of edema was attributed to reperfu-
sion initially and then to inﬂammatory cell inﬁltration.16
Tissue hemorrhage is typically characterized by an acute
primary phase16 and then potentially by secondary hemorrhagic
transformation in the subacute phase hours or days later.17,18
Deoxyhemoglobin has paramagnetic effects that enable
myocardial hemorrhage to be detected using T2- and T2*-
weighted CMR (T2* relaxation refers to the decay of transverse
magnetization seen with gradient-echo sequences.).19,20
Because myocardial hemorrhage is very common in swine after
40 minutes of ischemia,20 the observations by Fernandez-
Jimenez et al15 could be explained by myocardial hemorrhage;
however, the time course and relationships betweenmyocardial
edema and hemorrhage early after MI in patients after STEMI
are uncertain.
We hypothesized (1) that myocardial hemorrhage evolves
progressively after acute STEMI, with incident hemorrhage
occurring in some patients immediately after reperfusion,
followed by a secondary phase of progressive hemorrhage; (2)
that T2 and T2* relaxation times (in ms) within the infarct zone
exhibit similar temporal changes when measured at serial time
points after MI; and (3) that temporal changes in edema,
reﬂected by the T2 relaxation time (in ms), and its bimodal
pattern are inversely associated with the amount of hemor-
rhage. Our study was designed to provide novel and clinically
relevant insights into the temporal evolution of myocardial
hemorrhage and edema immediately after reperfusion and in
the longer term after MI.
Methods
Study Population and STEMI Management
To examine these hypotheses, we performed a comprehen-
sive longitudinal CMR study of myocardial hemorrhage and
edema in a cohort of reperfused patients after STEMI treated
by emergency percutaneous coronary intervention in a single
regional cardiac center between November 3, 2011, and
September 18, 2012. Thirty STEMI patients provided written
informed consent. The study was approved by the institutional
review board of West of Scotland Research Ethics Committee
(National Research Ethics Service reference 10-S0703-28).
Acute STEMI management followed contemporary guideli-
nes21,22 (Data S1). The study was publically registered
(ClinicalTrials.gov identiﬁer NCT02072850).
CMR Acquisition
CMR was performed on 4 occasions (4–12 hours and
3 days, 10 days, and 7 months) after reperfusion using a
Siemens Magnetom Avanto 1.5T scanner with a 12-element
phased array cardiac surface coil.23,24 The imaging proto-
col25,26 included cine CMR with steady-state free precession
for imaging cardiac anatomy and left ventricular mass and
function, T2* mapping for speciﬁcally imaging myocardial
hemorrhage based on dephasing of T2* relaxation times, T2
mapping27,28 for imaging myocardial edema based on tissue
water content and mobility, and contrast-enhanced phase-
sensitive inversion-recovery pulse sequences29 for imaging
infarct scar and microvascular obstruction. CMR acquisition is
described in detail in Data S1.
CMR Analyses
The images were analyzed on a Siemens workstation by
observers with at least 3 years of CMR experience (N.A., D.C.,
I.M., S.R., G.C.) (Data S1).
Quantitative assessments of myocardial edema (T2)
and myocardial hemorrhage (T2*): standardized
measurements in myocardial regions of interest
Left ventricular contours were delineated with computer-
assisted planimetry on the raw T2* image and the last
corresponding T2 raw image, with echo time of 55 ms30,31
(Data S1). T2 values from an age-matched healthy population
were taken to represent baseline values (Data S1).
Myocardial hemorrhage
Myocardial hemorrhage was scored visually using T2* CMR
maps. Myocardial hemorrhage was visually deﬁned as a
hypointense area in the center (ie, core) of the edematous
zone with a mean T2* value of at least 2 SD below the T2*
value at the periphery of the edematous zone and, on average,
measuring <20 ms, with a minimum area of 1% left ventricular
mass.32–35 Myocardial hemorrhage was described as per-
centage of left ventricular mass.
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Infarct deﬁnition and size
The myocardial mass of late gadolinium (in g) was quantiﬁed
using computer-assisted planimetry (Data S1).23,36
Myocardial edema
The territory of myocardial edema was deﬁned as left
ventricular myocardium with pixel values (T2) >2 SD from
remote myocardium.13,14,37–40
Myocardial salvage
Myocardial salvage was calculated by subtraction of percent-
age of infarct size from percentage of area at risk.13,40 The
myocardial salvage index was calculated by dividing the
myocardial salvage area by the initial area at risk.
Adverse remodeling
Adverse remodeling was deﬁned as an increase in left
ventricular end-diastolic volume ≥20% at 7 months from
baseline.41
Electrocardiogram
A 12-lead electrocardiogram was obtained before coronary
reperfusion and 60 minutes afterward (Data S1).
Biochemical Assessment of Infarct Size
Troponin T was measured (Elecsys Troponin T; Roche) as a
biochemical measure of infarct size. The highly sensitive
assay reaches a level of detection of 5 pg/mL and achieves
<10% variation at 14 pg/mL, corresponding to the 99th
percentile of a reference population. A blood sample was
routinely obtained 12 to 24 hours after hospital admission,
typically between 7 and 9 AM.
Statistical Analyses
Differences between independent groups were assessed
using t tests, Mann–Whitney tests, or Fisher exact tests, as
appropriate. Changes over time were assessed using gener-
alized linear mixed-effects models with time and hemorrhage
as ﬁxed effects and participant identiﬁer as the only random
effect. These models were ﬁtted as full factorial models, with
the interaction being removed only when not signiﬁcant. Post
hoc multiple comparisons were performed with Tukey adjust-
ment. Random-effects models were used to compute inter-
and intrarater reliability measures (intraclass correlation
coefﬁcient) for the reliability of remote zone, infarct zone,
and infarct core edema (T2) and myocardial hemorrhage (T2*)
values measured independently by 2 observers in 20 patients
selected randomly from the cohort. All statistical analyses
were carried out using R version 2.15.1 (R Foundation for
Statistical Computing) or SAS version 9.3 (SAS Institute) or
later versions of these programs. P>0.05 indicated the
absence of evidence for a statistically signiﬁcant effect.
Results
Thirty STEMI patients (mean age 54 years, 83% male)
(Table 1) treated by primary percutaneous coronary interven-
tion gave informed consent and underwent serial CMR at 1.5
T on 4 occasions (Figure 1). The CMR examinations were
performed (meanSD) 8.63.1 hours, 2.91.5 days,
9.62.3 days, and 21327 days following primary percuta-
neous coronary intervention (Table 2). Evaluable myocardial
edema (T2) and hemorrhage (T2*) data were available in 117
(98%) and 102 (85%) CMR scans, respectively. Information on
vital status was available in all of the participants. The mean
myocardial T2 value obtained from 50 healthy volunteers
(mean age 54 years [SD 13 years], 26 [52%] male) was 49.5
ms (SD 2.5 ms).
The size of infarction as revealed by the troponin
concentration was greater in patients with myocardial hem-
orrhage compared with patients without myocardial hemor-
rhage (Table 1).
Temporal Evolution of Myocardial Hemorrhage
Following Ischemia–Reperfusion
Thirteen (43%) patients developed myocardial hemorrhage by
day 3. Overall, myocardial hemorrhage occurred in 7 (23%), 13
(43%), 11 (33%), and 4 (13%) patients at 4 to 12 hours,
3 days, 10 days and 7 months, respectively (Table 2). Clinical
case examples are shown in Figure 2. In patients with
myocardial hemorrhage, the amount of hemorrhage (percent-
age of left ventricular mass) increased progressively from 4 to
12 hours to a peak at 3 days (P=0.0041) and then decreased
progressively at 10 days and 7 months (P<0.05) (Table 2 and
Figure 3). The opposite pattern was seen with myocardial
hemorrhage (T2* core values) with a nadir at day 3 versus 4 to
12 hours (P<0.001) and an increase between day 10 and
7 months (P=0.055) (Table 3).
Temporal Evolution of Myocardial Edema
The extent of myocardial edema (percentage of left ventricular
mass) increased from the initial CMR scan 4 to 12 hours after
MI to a maximum 3 days after MI and then reduced at
10 days and 7 months after MI (Table 2). The extent of
edema (percentage of left ventricular mass) was associated
with time from reperfusion (Table 2; Figure S1). Speciﬁcally,
edema was less at day 10 versus day 3 in patients with or
without myocardial hemorrhage (P<0.001 for interaction). In
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Table 1. Clinical and Angiographic Characteristics of the 30 Patients in the Longitudinal Clinical Study
Characteristics*
All Patients
n=30
No Myocardial Hemorrhage
(T2* Core Negative)
n=17 (57%)
Myocardial Hemorrhage
(T2* Core Positive)
n=13 (43%) P Value
Clinical
Age, y 54 (10) 55 (9) 53 (11) 0.602
Male sex, n (%) 25 (83) 15 (88) 10 (77) 0.628
BMI, kg/m2 28 (5) 29 (4) 27 (5) 0.257
History
Hypertension, n (%) 8 (27) 5 (29) 3 (23) 1.000
Current smoking, n (%) 21 (70) 11 (65) 10 (77) 0.691
Hypercholesterolemia, n (%) 13 (43) 7 (41) 6 (46) 1.000
Diabetes mellitus†, n (%) 2 (7) 1 (6) 1 (8) 1.000
Previous angina, n (%) 3 (10) 1 (6) 2 (15) 0.565
Previous myocardial infarction, n (%) 1 (3) 1 (6) 0 (0) 1.000
Previous PCI, n (%) 1 (3) 1 (6) 0 (0) —
Presenting characteristics
Heart rate, bpm 77 (17) 75 (19) 81 (14) 0.340
Systolic blood pressure, mm Hg 141 (26) 139 (33) 143 (16) 0.712
Diastolic blood pressure, mm Hg 84 (12) 83 (13) 86 (11) 0.472
Time from symptom onset to
reperfusion, min, median (IQR)
156 (112–243) 161 (118–206) 137 (112–274) 0.837
Ventricular fibrillation‡, n (%) 1 (3) 1 (6) 0 (0) 1.000
Heart failure, Killip class at
presentation, n (%)
I 22 (74) 13 (76) 9 (69) 0.811
II 7 (23) 4 (24) 3 (23)
III/IV 1 (3) 0 (0) 1 (8)
Electrocardiogram
ST-segment elevation resolution after
PCI, n (%)
Complete, ≥70% 15 (50) 1 (6) 1 (8) 1.000
Partial, 30% to <70% 13 (43) 7 (41) 6 (46)
None, ≤30% 2 (7) 9 (53) 6 (46)
Number of diseased arteries§, n (%)
1 14 (47) 10 (58) 4 (31) 0.298
2 11 (37) 5 (29) 6 (46)
3 5 (17) 2 (12) 3 (23)
Culprit artery, n (%)
LM 0 (0) 0 (0) 0 (0)
LAD 9 (30) 4 (24) 5 (38) 0.112
LCX 10 (33) 4 (24) 6 (46)
RCA 11 (37) 9 (53) 2 (15)
TIMI coronary flow grade before PCI, n (%)
0/1 24 (80) 12 (71) 12 (92) 0.196
2/3 6 (20) 5 (29) 1 (8)
Continued
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addition, the end-diastolic wall thickness measured in the
infarct zone decreased over time (P<0.001) (Table S1).
Temporal Evolution of Infarct Size, Myocardial
Salvage in Relation to Hemorrhage Status
Infarct size reduced with time from MI onset, and although the
absolute reduction in infarct size was greater in patients with
hemorrhage compared with patients without hemorrhage
(Table 2), the relative reduction was similar. Myocardial
salvage was associated with the timing of the CMR, and the
amount of salvageable myocardium was less in the patients
with hemorrhage than in patients without hemorrhage
(Table 2).
Temporal Evolution of Myocardial Edema and
Myocardial Hemorrhage
With regard to infarct zone edema (T2 values), when study
participants were grouped according to the presence or
absence of myocardial hemorrhage, a bimodal pattern was
observed. In patients with myocardial hemorrhage, a bimodal
time course in edema (T2 values) was observed within the
edematous zone (P<0.001 for interaction) and the infarct core
(P=0.0083 for interaction) (Table 3, Figure 3). In contrast, this
pattern differed in patients without myocardial hemorrhage in
whom T2 values increased progressively up to 10 days after
MI (P=0.042). By 7 months, edema (T2) had reduced in both
groups; however, in patients with myocardial hemorrhage,
edema (T2) remained higher in the infarct zone compared with
T2 values in the remote zone (P=0.001) and those of healthy
volunteers (P<0.001). They also tended to be higher than
edema (T2 values) in the infarct zone of patients without
hemorrhage (P=0.059) (Table 3). These observations imply
that the temporal changes in edema and hemorrhage are
correlated.
T2 in the myocardial remote zone increased over time in
patients both with and without myocardial hemorrhage
(P<0.001 for interaction) but to a greater extent in patients
with hemorrhage (Table 2).
Intra- and interobserver agreement of T2 and T2*
measurements
Myocardial edema (T2 values) and myocardial hemorrhage
(T2* values) in regions of interest in remote zones, injured
zones, and infarct core in a subgroup of 20 randomly
chosen patients were measured independently by 2
observers (Figures S1–S6). The intraclass correlation coef-
ﬁcients for reliability of infarct zone T2*, infarct core T2*,
infarct zone T2, and infarct core T2 were 0.75 (95% CI
0.47–0.89), 0.90 (95% CI 0.77–0.96), 0.89 (95% CI 0.74–
0.95), and 0.86 (95% CI 0.68–0.94; all P<0.001), respec-
tively. Bland-Altman plots showed no evidence of bias
(Figures S1–S6).
Table 1. Continued
Characteristics*
All Patients
n=30
No Myocardial Hemorrhage
(T2* Core Negative)
n=17 (57%)
Myocardial Hemorrhage
(T2* Core Positive)
n=13 (43%) P Value
TIMI coronary flow grade after PCI, n (%)
0/1 0 (0) 0 (0) 0 (0) 1.000
2 2 (7) 1 (6) 1 (8)
3 28 (93) 16 (94) 12 (92)
Medical therapy
ACEI or ARB 30 (100) 17 (100) 13 (100) —
Beta blocker 30 (100) 17 (100) 13 (100) —
Initial blood results on admission
Neutrophil count, 9109 L 10.1 (3.1) 9.3 (3.0) 11.3 (3.0) 0.083
NT-proBNP, pg/mL, median (IQR) 588 (306–1541) 529 (301–1254) 864 (655–1637) 0.841
Troponin T, ng/L, median (IQR) 3136 (1710–6608) 1804 (1126–3427) 6598 (5244–11 190) 0.001
ACEI indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; bpm, beats per minute; IQR, interquartile range; LAD, left anterior
descending; LCX, left circumﬂex; LM, left main; NT-proBNP indicates N-terminal pro–brain natriuretic peptide; PCI, percutaneous coronary intervention; RCA, right coronary artery; TIMI,
Thrombolysis in Myocardial Infarction.
*Data are reported as mean (SD), median (IQR), or N (%) as appropriate.
†Diabetes mellitus was deﬁned as a history of diet-controlled or treated diabetes.
‡Successfully electrically cardioverted ventricular ﬁbrillation at presentation or during emergency PCI procedure.
§Multivessel coronary artery disease was deﬁned according to the number of stenoses of at least 50% of the reference vessel diameter, by visual assessment and whether or not there was
left main stem involvement.
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Figure 1. Study ﬂow diagram. CMR indicates cardiac magnetic resonance; STEMI, ST-segment elevation
myocardial infarction.
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Temporal Relationships Between Intramyocardial
Hemorrhage and Left Ventricular Outcomes From
<12 Hours to 7 Months After Reperfusion
Left ventricular mass decreased from 14026 g at 3 days
after MI to 11926 g at 7 months after MI (P=0.003). By
7 months after MI, left ventricular ejection fraction tended to
increase (569% versus 598%, P=0.061), and infarct size
(percentage of left ventricular mass) tended to be smaller
(2013% versus 1410%; P=0.10).
At 3 days after MI, compared with patients without
hemorrhage, patients with hemorrhage had a greater amount
of myocardial edema (percentage of left ventricular mass
448% versus 3513%; P=0.007) and a lower left ventricular
ejection fraction (528% versus 588%; P=0.042) (Table 2).
Left ventricular ejection fraction increased in both groups
across the time points (Table 2); however, there was an
interaction between ejection fraction and myocardial hemor-
rhage status (P<0.001), and there was less improvement in
ejection fraction in patients with myocardial hemorrhage
compared with those patients without myocardial hemor-
rhage.
Left ventricular end-diastolic volume increased over time in
patients with myocardial hemorrhage (P=0.001) (Table 2). In
contrast, left ventricular end-diastolic volume reduced over
time in patients without hemorrhage (Table 2). Left ventric-
ular end-diastolic volume was greater at 7 months versus 4
to 12 hours after MI in patients with hemorrhage compared
with patients without hemorrhage (P=0.0133). At day 3 after
MI, infarct size was greater in patients with hemorrhage
compared with patients without hemorrhage (P<0.001)
(Table 2).
Table 2. Comparison of CMR Findings in Patients With Versus Without Myocardial Hemorrhage (Day 3)
Myocardial Hemorrhage
4 to 12 Hours 3 Days 10 Days 7 Months P Value*
Yes No Yes No Yes No Yes No All Yes No
LV ejection
fraction, %
50 (7) 54 (10) 52 (8) 58 (8) 56 (9) 61 (7) 55 (8) 62 (7) <0.001 <0.001 <0.001
LV end-diastolic
volume, mL
160 (36) 160 (31) 163 (33) 161 (30) 169 (35) 160 (31) 176 (35) 154 (31) 0.698 0.001 0.377
Myocardial edema,
% LV mass
39 (9) 31 (9) 44 (8) 35 (13) 36 (9) 28 (13) — — <0.001 <0.001 0.029
Infarct size,
% LV mass
29 (13) 12 (8) 30 (12) 12 (7) 22 (9) 9 (5) 22 (9) 8 (4) <0.001 <0.001 <0.001
Myocardial salvage,
% LV mass,
median (IQR)
5 (5, 15) 16
(11, 28)
11
(8, 20)
22
(14, 27)
13 (8, 16) 17
(12, 25)
23
(16, 27)
25
(16, 34)
<0.001 <0.001 0.003
Microvascular
obstruction, n (%)
13 (100) 5 (29) 13 (100) 4 (24) 9 (69) 1 (6) 0 (0) 0 (0)
T2 map hypointense
core, n (%)
7 (54) 12 (71) 13 (100) 5 (29) 10 (77) 4 (24) 1 (8) 0
Myocardial
hemorrhage,
n (%)
7 (54) 0 (0) 13 (100) 0 (0) 11 (85) 0 (0) 4 (31) 0 (0)
Myocardial
hemorrhage,
% LV mass,
median (IQR)
2.7
(0.0–5.6)
0 7.0
(4.9–7.5)
0 4.1
(2.6– 5.5)
0 0 (0– 0) — — <0.001 —
CMR scans were obtained <12 hours, 3 days, 10 days, and 7 months after reperfusion. The P values for the interaction for the effects of time and hemorrhage in linear mixed-effects
models are reported in the footnote. Missing data: Overall, 3, 2, 3, and 6 patients did not undergo evaluation of T2* at 4 to 12 hours, day 3, day 10, and 7 months, respectively. In addition,
1 patient did not undergo T2 analysis at 4 to 12 hours, day 10, or 7 months. At day 3, the presence of hemorrhage could be visually classiﬁed in all participants; however, T2*
measurements (in ms) were affected by motion artifact and could not be reliably analyzed in all participants. The presence of myocardial hemorrhage is maximal at day 3, and the
occurrence of infarct pathology at other time points is expressed as a proportion of those with (n=13) or without (n=17) myocardial hemorrhage on day 3. One patient did not have a T2
edema imaging map at 4 to 12 hours, day 10, or 7 months. Continuous data are expressed as mean (SD) except for myocardial salvage and myocardial hemorrhage, which are summarized
as median (interquartile range). T2 hypointense core was delineated using T2 mapping. Five patients had no evidence of a T2* hypointense core at 4 to 12 hours and subsequently
developed a T2* core on day 3. One patient’s scan was not evaluable at 4 to 12 hours because of motion artifact, but there was evidence of T2* core on day 3. CMR indicates cardiac
magnetic resonance; IQR, interquartile range; LV, left ventricular.
*Generalized linear mixed-effects models for the effects of hemorrhage and time point were used to obtain P values. P values are not presented for categorical data because the model is
not supported for this function. Interactions were observed for LV ejection fraction (P<0.001), LV end-diastolic volume (P=0.022), myocardial edema (P<0.001), infarct size (P<0.001), and
myocardial salvage (P<0.0001).
DOI: 10.1161/JAHA.115.002834 Journal of the American Heart Association 7
Myocardial Hemorrhage Time Course After STEMI Carrick et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on May 1, 2019
T2* Relaxation Times in the Myocardial Remote
Zones and in Healthy Volunteers
T2* values in the remote zone did not change over time
(P=0.361 for patients with myocardial hemorrhage;
P=0.876 for patients without hemorrhage), and these
values were similar to T2* values in healthy controls
(supplementary ﬁle). At 7 months, in patients with myocar-
dial hemorrhage at 3 days after MI, T2* values in the infarct
zone remained reduced compared with the remote zone,
whereas in patients without hemorrhage, T2* values in the
infarct zone were similar to T2* values in the remote zone
(Table 3).
Discussion
We undertook the ﬁrst longitudinal clinical study of myocar-
dial hemorrhage involving serial contrast-enhanced CMR on 4
occasions in patients after STEMI. For the ﬁrst time, the
temporal evolution of myocardial infarct pathologies was
assessed acutely from within 12 hours of reperfusion to
6 months after STEMI.
A
B
Figure 2. Cardiac magnetic resonance T2 mapping, T2* mapping, and contrast-enhanced images at 4
time points after reperfusion from patients without (A) and with (B) myocardial hemorrhage, following
emergency percutaneous coronary intervention (Data S2). MRI indicates magnetic resonance imaging.
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Our study had several main ﬁndings. First, the overall
incidence of myocardial hemorrhage was 43%. Second,
approximately one-quarter of the patients had evidence of
myocardial hemorrhage 4 to 12 hours after MI, and hemor-
rhage detection increased progressively, with 20% of new cases
at 3 days compared to 4 to 12 hours, and hematoma persisted
at 10 days and 7 months in 11 (37%) and 4 (13%) patients,
respectively. Third, myocardial edema (T2 values) evolves with a
bimodal time course in patients with myocardial hemorrhage
but with a unimodal time course in patients without myocardial
hemorrhage (Table 2). Fourth, T2*within the hemorrhagic core
followed a similar pattern to T2, with a nadir in both on day 3.
Fifth, during the ﬁrst 10 days after reperfusion, myocardial
edema (T2 values) within the infarct zone and hypointense core
had a bimodal distribution in patients with myocardial hemor-
rhage, whereas myocardial edema had a unimodal progressive
A
B C
Figure 3. A, Time course of myocardial edema, reﬂected by T2 relaxation times (in ms) in patients with
ST-segment elevation myocardial infarction with or without myocardial hemorrhage during the ﬁrst 10 days
after ischemia–reperfusion (Data S2). Edema (T2 values) evolved with a bimodal time course in patients
with myocardial hemorrhage but with a unimodal time course in patients without hemorrhage. The red
continuous red line links edema T2 relaxation times in the infarct core. The interrupted blue line links
edema T2 relaxation times in the infarct zone. Because cardiac magnetic resonance scans were not
obtained before reperfusion, the baseline mean T2 values are imputed T2 values at the midventricular level
obtained from age-matched healthy volunteers. B, The amount of myocardial edema (% LV mass) evolved
with a unimodal time course to a maximum on day 3. C, Amount of myocardial hemorrhage in the subgroup
of patients with hemorrhage. In a linear mixed-effects model, the amount of myocardial hemorrhage across
the time points of assessment was not associated with infarct size (P=1.0). %LV mass indicates percentage
of left ventricular mass.
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increase in patients without myocardial hemorrhage. Sixth,
changes in edema (T2 values) were inversely related to the
occurrence and extent of hemorrhage. Seventh, myocardial
hemorrhage was associated with sustained reductions in left
ventricular ejection fraction and adverse left ventricular
remodeling from baseline to 7 months.
Based on these observations, we concluded that myocar-
dial hemorrhage increases progressively after reperfusion,
with a primary hyperacute phase <12 hours after MI culmi-
nating in a peak 3 days later. The temporal changes in
myocardial edema, reﬂected by T2 relaxation times, are
inversely associated with myocardial hemorrhage. Our results
provide further evidence that myocardial hemorrhage is an
adverse prognostic complication after MI, but the interval
between days 1 and 3—potentially a phase of secondary
hemorrhage—suggests that a therapeutic window may exist
in which to prevent hemorrhage should targeted therapies
become available in the future.
Our clinical data provided new insights into experimental
observations of the time course of myocardial edema by
Fernandez-Jimenez et al.15,16 They described a bimodal
pattern of myocardial edema with peaks of percentage
myocardial water content and myocardial edema (T2 values)
acutely at 2 hours after reperfusion and 7 days later,
associated with an intervening decrease in myocardial water
content at 24 hours. They concluded that myocardial edema
occurred in 2 waves, the ﬁrst occurring abruptly after
reperfusion and a second “deferred wave of edema” appear-
ing progressively in relation to inﬂammation and healing.15
There could be alternative explanations for the “second
wavefront of edema,” including (1) a reduction in infarct tissue
mass and a relative increase in percentage water or (2) an
increase in the wet weight of tissue due to progressive
myocardial hemorrhage or hemorrhagic transformation.17,18
Our analysis supports the latter. Oxidative denaturation of
hemoglobin evolves over 1 to 3 days,19 and the product,
deoxyhemoglobin, has paramagnetic effects that destroy T2
signal (ie, the relaxation time becomes shorter). Our results
are consistent with concomitant oxidative denaturation and
paramagnetic destruction of the T2 signal within the infarct
core, as noted in earlier preclinical32 and clinical42 observa-
tions. Consequently, the peak in myocardial hemorrhage that
we observed 3 days after MI likely explains the reductions in
colocalized reduction in T2 values at this time point, giving the
false impression that edema is also reduced. In other words,
the T2 signal associated with water content and mobility is
reduced by the paramagnetic effects of deoxyhemoglobin, but
—distinct from this magnetic resonance phenomenon—
tissue water content (edema) may be unchanged. Our
observations provide an alternative explanation for the
bimodal distribution in T2 values that was observed by
Fernandez-Jimenez et al.15 In contrast, we observed that the
amount of myocardial edema had a unimodal evolution
regardless of the presence or absence of hemorrhage.
The apparent progression of myocardial hemorrhage over
time in some patients is consistent with hemorrhagic
transformation after tissue infarction, which is especially
relevant to reperfused STEMI patients who have been treated
with antithrombotic therapies.17,19
Based on morphological2 and functional studies,43
microvascular obstruction may have structural and functional
components,44 reﬂecting irreversible (ie, endothelial disrup-
tion) and reversible (eg, microvascular spasm, extrinsic
edema) components. Myocardial hemorrhage reﬂects the
aggregation and extravasation of erythrocytes4,20,45 and is a
manifestation of severe microvascular injury. On CMR at day
Table 3. Myocardial Edema and Myocardial Hemorrhage in the Ischemic and Remote Zones for the Serial Imaging Subset (n=30)
at 4 Successive Time Points After Reperfusion, Stratiﬁed by the Presence or Absence of Myocardial Hemorrhage on Day 3
Timing of MRI
4–12 Hours
n=30
3 Days
n=30
10 Days
n=30
7 Months
n=30
IMH (Day 3)* Yes No Yes No Yes No Yes No All Yes No
T2* infarct zone, ms 29.2 (5.8) 37.7 (3.3) 26.6 (4.8) 39.6 (3.5) 28.6 (3.3) 37.0 (4.3) 29.2 (4.0) 32.7 (2.0) 0.018 0.095 <0.001
T2* infarct core, ms 17.8 (6.0) — 14.1 (4.1) — 16.7 (5.9) — 18.9 (6.2) — — <0.001 —
T2* remote zone, ms 31.9 (2.0) 32.4 (1.8) 32.9 (1.9) 32.3 (2.0) 32.6 (1.6) 32.0 (1.3) 32.4 (2.3) 32.3 (1.6) 0.478 0.361 0.876
T2 infarct zone, ms 62.8 (6.7) 62.1 (2.9) 61.4 (4.1) 64.4 (4.9) 68.1 (3.7) 65.9 (5.3) 54.0 (2.8) 52.0 (3.2) <0.001 <0.001 <0.001
T2 infarct core, ms 55.5 (6.9) 54.2 (2.6) 51.8 (4.6) 54.4 (4.5) 59.2 (3.6) 59.2 (4.4) — — <0.001 0.008 0.057
T2 remote zone, ms 48.5 (2.5) 48.5 (2.0) 49.3 (1.7) 48.7 (2.1) 50.5 (2.4) 49.2 (2.1) 50.3 (1.6) 50.0 (1.4) <0.001 0.002 0.003
Myocardial edema is shown as T2 relaxation times (in ms), and myocardial hemorrhage is shown as T2* relaxation times (in ms). The T2* infarct core values are given for only those
patients that had a T2* hypointense core to measure (n=7 at <12 hours, n=13 at day 3, n=11 at day 10 and n=4 at 7 months). IMH indicates intramyocardial hemorrhage; MRI, magnetic
resonance imaging.
*Generalized linear mixed-effects models for the effects of hemorrhage and time point were used to obtain P values. P values are not presented for categorical data because the model is
not supported for this function. Interactions in a model were observed for T2* infarct zone (in ms; P<0.001), T2* core (in ms; P<0.001), T2 infarct zone (in ms; P<0.001), T2 core (in ms;
P=0.0083), T2 remote zone (in ms; P<0.001), and remote zone wall thickness (in cm; P<0.001).
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3, 5 patients without evidence of hemorrhage on T2* imaging
had hypointense cores on T2 maps and microvascular
obstruction on contrast imaging. The mean T2 core value
for these patients was greater than that for patients with
hemorrhage (54.54.5 versus 51.84.6 ms; P=0.268). The
hypointense core on T2 maps in the absence of hemorrhage
likely represents a reduction in the amount of tissue water
within the infarct core related to obstructed capillary ﬂow,
consistent with microvascular obstruction (Table 2; Fig-
ure 3).28 The observation that the mean T2 core value is
lower in patients with hemorrhage is consistent with the
additional effect of paramagnetic depletion of the T2 signal.
Our results have important clinical implications. First, the
results provide new insights into the experimental concepts
proposed by Fernandez-Jimenez et al15,16 and Kim et al.11
Our results conﬁrmed that the extent of edema is not stable
and that the occurrence and temporal evolution of myocardial
hemorrhage inﬂuences other infarct characteristics such as
edema and microvascular obstruction, as revealed by edema
(T2-weighted) and contrast-enhanced CMR, respectively.
Second, our results should be helpful for planning the timing
of CMR imaging after MI for clinical and research purposes
and indicate that the extent of edema and size of infarction
decrease after 3 days. Third, our results provide further
information on the adverse prognostic associations between
myocardial hemorrhage and reductions in left ventricular
systolic function and adverse left ventricular remodel-
ing,5,7,46,47 and thus draw attention to the pathophysiological
importance of this complication. Finally, our results conﬁrm
that infarct pathologies evolve progressively after MI and thus
may be amenable to targeted preventative therapeutic
interventions. Robbers et al45 proposed that myocardial
hemorrhage was the ﬁnal consequence of severe microvas-
cular thrombosis and that therapeutic interventions that
restored microvascular perfusion might, in turn, prevent
myocardial hemorrhage. Observations in the current study
(Table 2; Figure 3) and by Robbers et al45 and Payne et al20
also support the notion that red blood cells may be “trapped”
in the microcirculation of the culprit coronary artery, reﬂecting
a contributing cause and/or consequence of microvascular
obstruction. Degradation of these red cells may also
contribute to local paramagnetic effects. Conceivably, intra-
coronary thrombolysis administered early after reperfusion
and before stent implantation might reduce coronary
thrombus burden and distal clot embolization, lyse microvas-
cular thrombi, and restore microvascular perfusion early
after MI. We are examining this hypothesis in a randomized,
double-blind, placebo-controlled, parallel group trial of
low-dose adjunctive alteplase during primary percutaneous
coronary intervention (T-TIME, ClinicalTrials.gov identiﬁer
NCT02257294).
Limitations
We do not have pathological validation of our imaging
results. Preclinical studies enable pathological validation15,32;
however, the corollary is a stepped reduction in sample size
and statistical power when histopathology is undertaken
(n=20 at 2 hours after MI versus n=5 at 7 days after MI15).
The sample size in our cohort was preserved across all time
points, and although the study population was limited in size
(n=30), the statistical power was preserved by paired (n=4)
assessments within the same participant and 100% follow-up
of all participants. In our study, CMR was not performed on
day 2, so a nadir in edema cannot be ruled out. Although
CMR was not possible before STEMI, we think it is
reasonable to believe that no hemorrhage was present in
the STEMI patients before the event, implying a “zero
baseline,” because remote T2 and T2* values in STEMI
patients were similar to those measured in healthy persons.
We acknowledge that the differences in edema (T2) and
hemorrhage (T2*) are within the interobserver range of
values and that our ﬁndings do not conﬁrm causality. We
also acknowledge that, expectedly, less deoxyhemoglobin
will be present in the hyperacute phase (<24 hours after
reperfusion, when oxyhemoglobin is the predominant form of
hemoglobin) compared with the postacute phase (days 1 to
<3), and that a possible explanation for the increase in the
extent of the hypointense core on T2* CMR mapping is an
increase in deoxyhemoglobin content within the hema-
toma.48 Further research is warranted.
Conclusion
Myocardial hemorrhage peaked at day 3 after MI in
reperfused STEMI patients, and that explains the reduction
in T2 values and the bimodal pattern. Myocardial edema has a
unimodal time course.
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